Combining PARP inhibition and androgen receptor-signalling inhibition improves radiographic progression-free survival in HRR-deficient mCRPC Presented ByProf. Karim Fizazi, Institute Gustave Roussy, France TrialPhase 3, TALAPRO-2 ConferenceASCO 2023 2 August, 2023 09:24